Design Therapeutics (DSGN) Financials

$15.02

$-0.21 (-1.38%)

As on 09-Sep-2026 16:00EDT

Market cap

$947 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

4.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.00	0.62	0.60	0.54	0.47	0.13
Gross Profit	0.00	-0.62	-0.60	-0.54	-0.47	-0.13
Operating Expenses	79.36	78.85	61.79	77.65	67.59	35.83
Operating Profit (EBIT)	-79.36	-79.47	-62.38	-78.19	-67.59	-35.83
Other Income	--	--	--	--	4.29	0.30
Profit before Tax	-70.80	-69.79	-49.59	-66.86	-63.31	-35.53
Provision for Tax	--	--	--	0.00	-4.69	-0.11
Profit after Tax (Net Income)	-70.80	-69.79	-49.59	-66.86	-58.62	-35.53
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-63.31	-35.53

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	201.86	212.50	242.10	277.69	327.31	382.13
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.03	0.65	1.53	2.33	3.05	3.14
Current Liabilities	11.24	13.06	8.46	9.62	10.78	5.28
Total Liabilities	226.37	226.20	252.09	289.64	341.14	390.56

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	3.12	2.42	4.05	5.06	6.02	5.12
Current Assets	212.01	223.78	248.04	284.58	335.12	385.44
Total Assets	226.37	226.20	252.09	289.64	341.14	390.56
Total Debt*	2.03	1.54	2.33	3.05	3.69	3.63
Net Current Assets	200.77	210.73	239.58	274.96	324.34	380.15

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-54.36	-43.11	-58.56	-51.32	-29.38
Cash Flow from Investing Activities	--	22.91	43.96	52.54	-220.99	-53.64
Cash from Financing Activities	--	25.74	0.51	0.72	0.24	379.21
Net Cash Inflow / Outflow	--	--	--	--	-272.07	296.19

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.19	-1.22	-0.87	-1.19	-1.05	-0.64
Cash EPS ($)	--	-1.21	-0.86	-1.18	-1.04	-0.64
Adjusted Book Value ($)	--	3.71	4.27	4.95	5.86	6.90
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.95	-0.76	-1.04	-0.92	-0.53
Free Cash Flow per Share ($)	--	-0.95	-0.77	-1.05	-0.94	-0.56

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-30.45	-18.88	-21.86	-16.36	-18.98
ROE (%)	-34.17	-30.70	-19.08	-22.10	-16.52	-19.16
ROA (%)	-30.91	-29.18	-18.31	-21.20	-16.02	-16.64
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-1,367.96	-11,923.83
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	-1.00
EBIT Growth (%)	-14.68	-40.74	25.84	1.08	-90.23	-329.14
Net Profit Growth (%)	-11.51	-40.74	25.84	-14.07	-64.96	-329.14
EPS Growth (%)	-6.11	-0.39	0.27	-0.13	-0.63	-1.11
Book Value Growth (%)	-13.81	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-7.71	-7.05	-2.23	-9.78	-33.36
Price / Book Value	4.69	2.53	1.44	0.54	1.75	3.10
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.84	-4.62	-2.18	1.96	-3.67	-22.73
Close Price ($)	14.47	9.38	6.17	2.65	10.26	21.41
High Price ($)	17.25	10.31	7.77	10.72	26.30	50.50
Low Price ($)	3.33	2.60	2.25	1.94	6.94	12.52
Market Cap ($ Cr)	947.49	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.01	0.01	0.01	0.01
Short term debt to equity ratio	--	0.00	0.00	0.00	0.00	0.00
Current Ratio	18.86	17.14	29.31	29.58	31.10	72.96
Quick Ratio	18.86	--	--	--	31.20	72.72
Interest Coverage	--	--	--	--	-14.41	-119.24

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	-758.39	54.47	1,926.76
Payable days	--	1,320.65	1,264.28	1,688.52	1,820.37	4,273.99
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.